According to American Cancer Society (ACS), the cancers that most frequently affect men are prostate, colon, lung, and skin cancers. The most common men’s specific cancer in America, affecting 1 in 7 men, is prostate cancer. One new case occurs every 2.3 minutes and a man dies from prostate cancer every 18 minutes.
You probably didn’t know this shocking statistic, from the Prostate Cancer Foundation; a man is 35% more likely to be diagnosed with prostate cancer than a woman is to be diagnosed with breast cancer.
Yet, despite these realities we don’t talk as openly as women do about a serious health condition. There are disputes about screenings for prostate cancer specifically, but I am an advocate of screening– including not only the PSA but also the digital rectal exam. From the screenings, you and your doctor will determine if biopsies are needed to detect aggressive cancers that need immediate treatment but also pick up cancers that are “quasi cancer” and safe to watch rather than treat immediately. Over a five-to-10-year period, about a third of men whose cancers are considered low risk turn worse and require treatment. When prostate cancer is caught in the early stages the treatment options and outcomes are significantly better.
Nearly 3 million American men currently living with prostate cancer, Emory Healthcare is committed to providing the highest quality health care to its patients, with the most up-to-date treatment options available. A multidisciplinary prostate cancer team — involving urology medical oncology, radiation oncology, diagnostic imaging– at Saint Joseph’s Hospital and Emory’s Winship Cancer Institute have come together to move novel treatments for advanced prostate cancer forward.
Start today and take control of your wellness.
- Honestly discuss prostate cancer.
- Avoid cancer-causing activities like tobacco use and excessive drinking.
- Be proactive. Commit yourself to regular physical activity to maintain a healthy weight.
- Know your risks and your family history.
- Get regular check-ups; speak with your primary care physician about whether prostate screening is appropriate for you.
If you do not have one, find a primary physician through our Emory Healthcare Network or call Health Connection at 404-778-7777 to learn more from a registered nurse.
About Dr. Sanda
Martin G. Sanda, MD is chair of the Department of Urology at Emory University School of Medicine and Director of the Prostate Cancer Center at Emory’s Winship Cancer Institute.
As a urological surgeon specializing in cancers of the prostate and bladder, Sanda focuses on developing new surgical and non-surgical approaches to cancer care and to improving the quality of life among cancer survivors. Currently, he is spearheading studies that seek to develop urine tests for detecting prostate cancer; develop benchmarks for improving quality of life among cancer survivors; and develop innovative prostate cancer vaccines.
Cancer Clinical Study Leads to Video Tool for Prostate Cancer Patients
Two Patients Benefit from Two Alternative Treatment Options for Prostate Cancer
PSA Screening for Prostate Cancer – A Healthy Debate
Questions on Validity of PSA Test as Prostate Cancer Screening Tool
Prostate Cancer, To Screen or Not?
Winship Cancer Institute Website